✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹149 Cr.
P/E
42.68
  • Auro Laboratories
  • Vaishali Pharma
  • Aarey Drugs & Pharma
FAQs on Auro Laboratories Ltd. Shareprice

Auro Laboratories has given better returns compared to its competitors.
Auro Laboratories has grown at ~15.31% over the last 7yrs while peers have grown at a median rate of 3.0%

Yes, Auro Laboratories is expensive.
Latest PE of Auro Laboratories is 42.68, while 3 year average PE is 19.84.
Also latest EV/EBITDA of Auro Laboratories is 37.27 while 3yr average is 13.25.

Growth Table
  • Auro Laboratories Ltd.
  • Vaishali Pharma
  • Aarey Drugs & Pharma
Balance Sheet
  • Auro Laboratories Ltd.
  • Vaishali Pharma
  • Aarey Drugs & Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Auro Laboratories Ltd.
  • Vaishali Pharma
  • Aarey Drugs & Pharma
Cash Flow
  • Auro Laboratories Ltd.
  • Vaishali Pharma
  • Aarey Drugs & Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Auro Laboratories Ltd.
  • Vaishali Pharma
  • Aarey Drugs & Pharma
Quarterly Results
  • Auro Laboratories Ltd.
  • Vaishali Pharma
  • Aarey Drugs & Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Auro Laboratories Ltd. Financials

Balance sheet of Auro Laboratories is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Auro Laboratories is increasing.
Latest net debt of Auro Laboratories is ₹33.53 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹22.95 Crs.

The profit is oscillating.
The profit of Auro Laboratories is ₹3.48 Crs for TTM, ₹7.79 Crs for Mar 2024 and ₹2.44 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Auro Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech